What are the potential hematological effects of leuprolide therapy, including changes in red or white blood cell counts, and how can these be monitored?
Gaurav ChauhanContributor
What are the potential hematological effects of leuprolide therapy?
Share
Leuprolide can cause anemia by lowering red blood cell count. Monitoring involves regular CBC tests to track any changes in blood cell levels.
Leuprolide therapy may occasionally lead to decreased white blood cell counts, increasing infection risk. Periodic blood tests are recommended to assess hematological function.
Leuprolide may cause bone marrow suppression, leading to reduced WBC and RBC counts. Regular CBC monitoring is advised to track these changes.